Bastasa Jr., Recardo .

HRN: 13-11-69  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/09/2026
MUPIROCIN 2%, 15G (TUBE)
08/09/2026
08/15/2026
TOPICAL
2%
TID
IV Site Burn
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: